Search Results - "Molica, Carmen"

Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience by Molica, Carmen, Gili, Alessio, Nardelli, Carlotta, Pierini, Tiziana, Arniani, Silvia, Beacci, Donatella, Mavridou, Elena, Mandarano, Martina, Corinaldesi, Rodolfo, Metro, Giulio, Gorello, Paolo, Giovenali, Paolo, Cenci, Nunzia, Castrioto, Corrado, Lupattelli, Marco, Roila, Fausto, Mecucci, Cristina, La Starza, Roberta

“…Our work reports implementation of a useful genetic diagnosis for the clinical managment of patients with astrocytic tumors. We investigated 313 prospectively…”
Get full text

Corrigendum: A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: a case report by Colombo, Mara, Mondini, Patrizia, Minenza, Elisa, Foglia, Claudia, Mosconi, Annamaria, Molica, Carmen, Pistola, Lorenza, Ludovini, Vienna, Radice, Paolo

“…[This corrects the article DOI: 10.3389/fonc.2023.1102184.]…”
Get full text

A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM : A case report by Colombo, Mara, Mondini, Patrizia, Minenza, Elisa, Foglia, Claudia, Mosconi, Annamaria, Molica, Carmen, Pistola, Lorenza, Ludovini, Vienna, Radice, Paolo

“…The widespread adoption of gene panel testing for cancer predisposition is leading to the identification of an increasing number of individuals with clinically…”
Get full text

New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma by Pierini, Tiziana, Nardelli, Carlotta, Lema Fernandez, Anair Graciela, Pierini, Valentina, Pellanera, Fabrizia, Nofrini, Valeria, Gorello, Paolo, Moretti, Martina, Arniani, Silvia, Roti, Giovanni, Giovenali, Paolo, Lupattelli, Marco, Metro, Giulio, Molica, Carmen, Castrioto, Corrado, Corinaldesi, Rodolfo, Laurenti, Maria Elena, Ascani, Stefano, Mecucci, Cristina, La Starza, Roberta

“…Abstract The catalytic activity of human Telomerase Reverse Transcriptase (TERT) compensates for the loss of telomere length, eroded during each cell cycle, to…”
Get full text

Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations by Metro, Giulio, Baglivo, Sara, Bellezza, Guido, Mandarano, Martina, Gili, Alessio, Marchetti, Giovanni, Toraldo, Marco, Molica, Carmen, Reda, Maria Sole, Tofanetti, Francesca Romana, Siggillino, Annamaria, Prosperi, Enrico, Giglietti, Antonella, Di Girolamo, Bruna, Garaffa, Miriam, Marasciulo, Francesca, Minotti, Vincenzo, Gunnellini, Marco, Guida, Annalisa, Sassi, Monica, Sidoni, Angelo, Roila, Fausto, Ludovini, Vienna

“…Besides platinum-based chemotherapy, no established treatment option exists for advanced non-small-cell lung cancer (NSCLC) patients with exon 20 (Ex20ins)…”
Get full text

Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study by Foglietta, Jennifer, Ludovini, Vienna, Bianconi, Fortunato, Pistola, Lorenza, Reda, Maria Sole, Al-Refaie, Antonella, Tofanetti, Francesca Romana, Mosconi, Annamaria, Minenza, Elisa, Anastasi, Paola, Molica, Carmen, Stracci, Fabrizio, Roila, Fausto

“…Hereditary breast and ovarian cancers are mainly linked to variants in /2 genes. Recently, data has shown that identification of variants has an immediate…”
Get full text

KRAS mutational status and sensitivity to a reversible epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in EGFR wild type (WT) advanced non-small cell lung cancer (NSCLC) patients (pts) by Metro, Giulio, Duranti, Simona, Chiari, Rita, Bennati, Chiara, Molica, Carmen, Currà, Maria Francesca, Scafati, Chiara, Siggillino, Annamaria, Flacco, Antonella, Marcomigni, Luca, Ludovini, Vienna, Minotti, Vincenzo, Crinò, Lucio

“…Abstract only e18023 Background: Treatment with a reversible EGFR-TKI may benefit pts with EGFR WT advanced NSCLC, though to a much lesser extent than pts…”
Get full text

Response to afatinib in patients with advanced NSCLC previously treated with reversible EGFR inhibitors in a mono-institutional experience by Bennati, Chiara, Currà, Maria Francesca, Chiari, Rita, De Angelis, Verena, Minotti, Vincenzo, Metro, Giulio, Duranti, Simona, Molica, Carmen, Scafati, Chiara, Paglialunga, Luca, Pistola, Lorenza, Flacco, Antonella, Tofanetti, Francesca Romana, Siggillino, Annamaria, Baldelli, Elisa, Ludovini, Vienna, Crinò, Lucio

“…Abstract only e18101 Background: All mutated non-small cell lung cancer (NSCLC) patients (pts) previously treated with an EGFR reversibile inhibitor, develop,…”
Get full text

A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report by Colombo, Mara, Mondini, Patrizia, Minenza, Elisa, Foglia, Claudia, Mosconi, Annamaria, Molica, Carmen, Pistola, Lorenza, Ludovini, Vienna, Radice, Paolo

“…The widespread adoption of gene panel testing for cancer predisposition is leading to the identification of an increasing number of individuals with clinically…”
Get full text